Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
L03AB11
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
NDF-RT |
N0000178330
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
NDF-RT |
N0000178330
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
NDF-RT |
N0000178330
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
NDF-RT |
N0000178330
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
NDF-RT |
N0000178330
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
NDF-RT |
N0000178330
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
WHO-VATC |
QL03AB61
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
NDF-RT |
N0000178330
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
WHO-VATC |
QL03AB11
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
NDF-RT |
N0000178330
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
PEGASYS (AUTHORIZED: HEPATITIS B, CHRONIC)
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
NDF-RT |
N0000178330
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
FDA ORPHAN DRUG |
362911
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
FDA ORPHAN DRUG |
113898
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
LIVERTOX |
747
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
WHO-ATC |
L03AB61
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
NCI_THESAURUS |
C2491
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
NDF-RT |
N0000178330
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
FDA ORPHAN DRUG |
125299
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
NDF-RT |
N0000175521
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
PEGASYS (AUTHORIZED: HEPATITIS C, CHRONIC)
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1201560
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
100000092750
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
C100416
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
5158
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
Q46947FE7K
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
SUB16452MIG
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
DB00008
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
PEGINTERFERON ALFA-2A
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
KK-38
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
198153-51-4
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
DTXSID101028094
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
Peginterferon Alfa
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
8140
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
C33987
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
7871
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | |||
|
m8445
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | Merck Index | ||
|
120608
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY | RxNorm | ||
|
Q46947FE7K
Created by
admin on Sat Dec 16 10:30:21 GMT 2023 , Edited by admin on Sat Dec 16 10:30:21 GMT 2023
|
PRIMARY |
ACTIVE MOIETY